PRESS RELEASE published on 08/07/2025 at 08:59, 1 year 1 month ago RHÖN-KLINIKUM AG closes first half of 2025 with solid results RHÖN-KLINIKUM AG closes first half of 2025 with solid results including revenue growth and stable EBITDA. Management focuses on sustainable operations despite industry challenges Financial Results EBITDA Revenue Growth Healthcare Sector RHÖN-KLINIKUM AG
BRIEF published on 05/08/2025 at 09:04, 1 year 4 months ago RHÖN-KLINIKUM AG Maintains Steady Performance in Q1 2025 Revenue Growth Future Outlook RHÖN-KLINIKUM AG German Healthcare Q1 2025 Results
BRIEF published on 05/08/2025 at 09:04, 1 year 4 months ago RHÖN-KLINIKUM AG maintient une performance stable au premier trimestre 2025 Croissance Des Revenus Perspectives D'avenir RHÖN-KLINIKUM AG Résultats Du Premier Trimestre 2025 Système De Santé Allemand
PRESS RELEASE published on 05/08/2025 at 08:59, 1 year 4 months ago RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed RHÖN-KLINIKUM AG reports steady performance in Q1 2025 with revenue up by 8.3% to EUR 414.7 million. Future outlook confirmed with revenue expected to reach EUR 1.7 billion in 2025 Revenue Healthcare Outlook RHÖN-KLINIKUM AG Q1 2025
BRIEF published on 03/27/2025 at 10:04, 1 year 5 months ago RHÖN-KLINIKUM AG Reports Strong Financial Year Amid Leadership Change Strategic Partnerships Financial Performance Leadership Change Sustainability Targets Healthcare Growth
BRIEF published on 11/07/2024 at 09:04, 1 year 10 months ago RHÖN-KLINIKUM AG affiche des progrès constants au troisième trimestre 2024 Croissance Des Revenus Perspectives Financières Secteur De La Santé Résultats Du 3ème Trimestre 2024 Clinique RHÖN AG
BRIEF published on 11/07/2024 at 09:04, 1 year 10 months ago RHÖN-KLINIKUM AG Shows Steady Progress in Q3 2024 Revenue Growth Healthcare Sector Financial Outlook RHÖN-KLINIKUM AG Q3 2024 Results
PRESS RELEASE published on 11/07/2024 at 08:59, 1 year 10 months ago RHÖN-KLINIKUM AG continues solid performance in the first nine months – outlook confirmed RHÖN-KLINIKUM AG reports increased revenues and profit in the first nine months of 2024. EBITDA up by 2.3%. Outlook for 2024 confirmed amidst global uncertainties Revenues EBITDA Outlook Profit RHÖN-KLINIKUM AG
BRIEF published on 08/08/2024 at 09:05, 2 years 1 month ago Premier semestre 2024 : RHÖN-KLINIKUM AG poursuit sa bonne performance commerciale – perspectives confirmées Hausse Des Revenus Secteur De La Santé RHÖN-KLINIKUM AG Résultats Financiers 2024 Augmentation Des Bénéfices
BRIEF published on 08/08/2024 at 09:05, 2 years 1 month ago First Half of 2024: RHÖN-KLINIKUM AG Continues Good Business Performance – Outlook Confirmed Revenue Growth Healthcare Sector Profit Increase RHÖN-KLINIKUM AG 2024 Financial Results
Published on 09/12/2026 at 02:35, 1 day 10 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 14 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 15 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 20 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 19 hours 29 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 5 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 15 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 15 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 17 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 17 hours ago Availability of the 2026 Interim Financial Report
